|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
READ-GENE S.A.
Main Activities: Health Care and Social Assistance
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name READ-GENE S.A. Headquarters ul. Akacjowa 2; Szczecin; Zachodniopomorskie ; 71-253 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational NIP: 8522464257 KRS: 0000242181 REGON: 320105636 Total Employees: 11 Tel: (91) 433-42-56 |
|
Company Description |
| Read-Gene SA is a medical company engaged in the detection, prevention and treatment of most common types of cancer. The company promotes genetic tests to detect cancer, dietary supplements reduce the risk of cancer and ways of action for the prevention, observation and treatment of the most common forms of cancer, or breast, ovarian, colon and prostate. |
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues increased with 0.98%, from PLN 700.02 thousands to PLN 706.85 thousands. Operating result decreased from PLN -433.34 thousands to PLN -649.66 thousands which means -49.92% change. The results of the period decreased -116.40% reaching PLN -863.88 thousands at the end of the period against PLN -399.2 thousands last year. Return on equity (Net income/Total equity) went from -8.31% to -21.92%, the Return On Asset (Net income / Total Asset) went from -3.62% to -7.69% and the Net Profit Margin (Net Income/Net Sales) went from -57.03% to -122.22% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 185.23% compared to 129.75% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.16 to 0.39 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| CorporateDB/Notoria | CorporateDB/Notoria | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
11,239 |
11,037 |
| ||
Current Assets |
282 |
438 |
| ||
Total Liabilities |
7,298 |
6,233 |
| ||
Shareholders Equity |
3,940 |
4,804 |
| ||
Current Liabilities |
717 |
377 |
| ||
| * All the accounts are in PLN. | ||
Income Statement
| ||
Total Operating Revenue |
706 |
700 |
| ||
Operational Profit (Loss) |
-649 |
-433 |
| ||
Net Profit (Loss) |
-863 |
-399 |
| ||
| * All the accounts are in PLN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-7.69% |
-3.62% |
| ||
Annualised Return on Assets (ROA) |
-7.69% |
-3.62% |
| ||
Return on Equity (ROE) |
-21.92% |
-8.31% |
| ||
Annualised Return on Equity (ROE) |
-21.92% |
-8.31% |
| ||
Return on Sales (ROS) |
-314.88% |
-109.78% |
| ||
Return on Capital |
-13.76% |
-6.2% |
| ||
Gross Profit Margin |
-323.15% |
-198.66% |
| ||
Operating Profit Margin |
-236.8% |
-119.17% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
1.87x |
30.15x |
| ||
Inventory Turnover |
17.07x |
|
| ||
Current asset turnover |
0.97x |
0.83x |
| ||
Fixed-asset turnover |
0.03x |
0.03x |
| ||
Asset Turnover |
0.02x |
0.03x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
-649 |
-433 |
| ||
EBITDA |
42 |
32 |
| ||
Enterprise value |
33,171 |
77,964 |
| ||
Enterprise Value / EBITDA |
788.48 |
2,379.87 |
| ||
Bookvalue (BV) |
3,940 |
4,804 |
| ||
Net Cash |
-651 |
46 |
| Liquidity Ratios | ||
| ||
Current Ratio |
39.4% |
116.21% |
| ||
Quick ratio |
29.92% |
116.21% |
| ||
Doom's day ratio |
9.09% |
112.43% |
| Leverage Ratios | ||
| ||
Leverage ratio |
285.23% |
229.75% |
| ||
Debt to equity |
185.23% |
129.75% |
| ||
Debt to total assets |
64.94% |
56.47% |
| ||
Long Term Debt to Capital |
37.24% |
25.39% |
| ||
Debt / Enterprise Value |
22% |
8% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
616.54 |
2,202.53 |
| ||
Price/Book Ratio |
6.58 |
15.02 |
| ||
Market Cap / Net cash |
-39.79 |
1,539.47 |
| Trend Ratios | ||
| ||
Revenue Trend |
95.55% |
64.81% |
| ||
Net Income Trend |
216.4% |
-122.58% |
| ||
Operating Income Trend |
149.92% |
-317.26% |
| ||
 |